Figure 2From: Favorable prognostic value of SOCS2 and IGF-I in breast cancerKaplan-Meier curve assessment of risk of death and risk of disease recurrence in 37 patients with lymph-node negative disease. Overall survival and relapse free survival (progression free survival) is shown for patients with high (17 pts.) and low (20 pts.) IGF-I expression.Back to article page